Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 2 (2006), Issue 10 (October)

1. British Association for Psychopharmacology Summer Meeting: 23-26 July 2006, Oxford, United Kingdom.
   Expert Opin Pharmacother, 7(14): 2007-10. [Abstract] [Full-text]
2. Clinical application of pharmacogenetics in gastrointestinal diseases.
   Expert Opin Pharmacother, 7(14): 1857-69. [Abstract] [Full-text]
3. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.
   Clin Cancer Res, 12(19): 5786-93. [Abstract] [Full-text]
4. QSAR study of antiplatelet agents.
   Bioorg Med Chem, 14(22): 7490-500. [Abstract] [Full-text]
5. Design, synthesis and evaluation of peptidomimetics based on substituted bicyclic 2-pyridones-targeting virulence of uropathogenic E. coli.
   Bioorg Med Chem, 14(22): 7563-81. [Abstract] [Full-text]
6. Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study.
   Bioorg Med Chem, 14(22): 7404-18. [Abstract] [Full-text]
7. Design, synthesis and antibacterial activity of novel 1,3-thiazolidine pyrimidine nucleoside analogues.
   Bioorg Med Chem, 14(22): 7476-81. [Abstract] [Full-text]
8. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
   Bioorg Med Chem, 14(22): 7419-33. [Abstract] [Full-text]
9. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
   Bioorg Med Chem, 14(22): 7625-51. [Abstract] [Full-text]
10. Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer.
    Cancer Sci, 97(11): 1255-9. [Abstract] [Full-text]
11. Bioinformatic analysis of protein structure-function relationships: case study of leukocyte elastase (ELA2) missense mutations.
    Hum Mutat, 27(12): 1230-43. [Abstract] [Full-text]
12. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Biochem Pharmacol, 72(10): 1197-206. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.